Generate a tailored SOP for Dr. Gerardo Turcatti. Improve your application with a focused, well-structured draft.
Gerardo Turcatti is an Adjunct Professor at the École Polytechnique Fédérale de Lausanne (EPFL), where he directs the Biomolecular Screening Facility (BSF), established in 2006. He has extensive experience in managing multidisciplinary technological projects, focusing on chemical biology. Turcatti is the project leader for the ACCESS program, which facilitates academic chemical screening in Switzerland as part of the NCCR-Chemical Biology framework. His previous work includes co-founding and serving as CTO at Manteia S.A., a Swiss company that specializes in high-throughput DNA sequencing technologies, currently under the ownership of Illumina, which utilizes 'Next Generation Sequencing' instruments. Turcatti has developed a long career in R&D within the biotechnology and pharmaceutical sectors, with significant expertise in Drug Screening, Chemical Biology, Bio-analytical Chemistry, and DNA-Protein Chemistry. He holds a Master's degree in Chemical Engineering from the University of Geneva and a PhD in Chemistry and Biochemistry from EPFL, where he was honored with the award for the best doctoral thesis of the year.
Standard requirements for Engineering and Basic Science Master's programs. Architecture requires an additional portfolio.